Personalized Medicine Market Worth $3.92 Trillion by 2026 - Insights Into Diagnostics, Medical Care, Nutrition & Wellness, and Therapeutics
DUBLIN, Feb. 20, 2020 /PRNewswire/ -- The "Global Personalized Medicine Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.
The Global Personalized Medicine market is expected to reach $3.92 trillion by 2026, growing at a CAGR of 12.1% during the forecast period.
The efficient and advanced technology and higher prevalence of disease are driving the market growth. However, the higher cost of research and developments is hampering the market.
Based on the End-user, the hospital's segment is estimated to have a lucrative growth due to the lower cost personalized medicines availability in the hospitals. As the practice of personalized medicine becomes more widespread, hospitals will also experience the need to adapt. That does not mean every hospital and medical centre should try and drive the science, but they should be open to collaborations to facilitate such work.
The key vendors mentioned are Abbott Laboratories, Affymetrix Incorporated, Agendia N.V, Agilent Technologies, Inc, Amgen, Inc, Asuragen Incorporated, Bayer Healthcare Pharmaceuticals, Llc, Celera Diagnostics LLC, Celgene Corporation, Roche Diagnostics Corporation, Precision Biologics Incorporated, Siemens Healthcare Diagnostics, Inc, Sigma-Aldrich Corporation, Johnson & Johnson, Novartis AG, Decode Genetics Inc., Exact Science Corporation, Exagen Diagnostics Inc., GE Healthcare, and Genelex Corporation.
Key Questions Answered in the Report
- How this market evolved since the year 2016
- Market size estimations, forecasts and CAGR for all the segments presented in the scope
- Key Market Developments and financials of the key players
- Opportunity Analysis for the new entrants
- SWOT Analysis of the key players
- Fastest growing markets analyzed during the forecast period
Key Topics Covered
1 Market Synopsis
2 Research Outline
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
5 Global Personalized Medicine Market, By Product
5.1 Introduction
5.2 Diagnostics
5.3 Personalized Medical Care
5.4 Personalized Nutrition & Wellness
5.5 Therapeutics
6 Global Personalized Medicine Market, By Technology
6.1 Introduction
6.2 Metabolomics
6.3 Pharmacodynamics
6.4 Pharmacogenetics
6.5 Pharmacogenomics
6.6 Pharmacokinetics
6.7 Pharmacoproteomics
6.8 Point-of-Care Testing
6.9 Stem Cell Therapy
7 Global Personalized Medicine Market, By Therapeutic Area
7.1 Introduction
7.2 Autoimmune Diseases
7.3 Blood Transfusion Safety
7.4 Cancer Management
7.5 Cardiovascular Diseases (CVD)
7.6 Central Nervous System (CNS) Disorders
7.7 Coagulation Therapy
7.8 Diabetes
7.9 Infectious Diseases
7.10 Antiviral
7.11 Neurology
7.12 Psychiatry
7.13 Oncology
7.14 Immunology
7.15 Respiratory
8 Global Personalized Medicine Market, By Distribution Channel
8.1 Introduction
8.2 Dietary Care Centers
8.3 Hospital's Pharmacies
8.4 Retail Pharmacies
8.5 Other Distribution Channels
9 Global Personalized Medicine Market, By Application
9.1 Introduction
9.2 Biomarker Identification
9.3 Clinical Research Applications
9.4 Companion Diagnostics
9.5 Health Informatics
10 Global Personalized Medicine Market, By End-user
10.1 Introduction
10.2 Academic Institutes
10.3 Bio and Health Informatics Companies
10.4 Clinical Care and Research Laboratories
10.5 Contract Research Organizations
10.6 Hospitals
10.7 Molecular Diagnostic Laboratories and Testing Facilities
10.8 Research Laboratories
10.9 Service Providers
10.10 Partner
10.11 Venture Capitalists
10.12 Other End-users
11 Global Personalized Medicine Market, By Geography
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 South America
11.5 Middle East & Africa
12 Strategic Benchmarking
13 Vendors Landscape
13.1 Abbott Laboratories
13.2 Affymetrix Incorporated
13.3 Agendia N.V
13.4 Agilent Technologies Inc.
13.5 Amgen Inc.
13.6 Asuragen Incorporated
13.7 Bayer Healthcare Pharmaceuticals, LLC
13.8 Celera Diagnostics LLC
13.9 Celgene Corporation
13.10 Roche Diagnostics Corporation
13.11 Precision Biologics Incorporated
13.12 Siemens Healthcare Diagnostics Inc.
13.13 Sigma-Aldrich Corporation
13.14 Johnson & Johnson
13.15 Novartis AG
13.16 Decode Genetics Inc.
13.17 Exact Science Corporation
13.18 Exagen Diagnostics Inc.
13.19 GE Healthcare
13.20 Genelex Corporation
For more information about this report visit https://www.researchandmarkets.com/r/37rw80
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/personalized-medicine-market-worth-3-92-trillion-by-2026---insights-into-diagnostics-medical-care-nutrition--wellness-and-therapeutics-301008591.html
SOURCE Research and Markets
